切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2021, Vol. 14 ›› Issue (04) : 539 -542. doi: 10.3877/cma.j.issn.1674-6902.2021.04.040

综述

姜黄素在肺部炎症性疾病中的免疫调节作用
顾艳利1, 宋勇1,(), 张方1,()   
  1. 1. 210002 南京,南京医科大学金陵临床医学院东部战区总医院呼吸内科
  • 收稿日期:2021-01-13 出版日期:2021-08-25
  • 通信作者: 宋勇, 张方

Immunomodulatory effects of curcumin in pulmonary inflammatory diseases

Yanli Gu1, Yong Song1(), Fang Zhang1()   

  • Received:2021-01-13 Published:2021-08-25
  • Corresponding author: Yong Song, Fang Zhang
引用本文:

顾艳利, 宋勇, 张方. 姜黄素在肺部炎症性疾病中的免疫调节作用[J/OL]. 中华肺部疾病杂志(电子版), 2021, 14(04): 539-542.

Yanli Gu, Yong Song, Fang Zhang. Immunomodulatory effects of curcumin in pulmonary inflammatory diseases[J/OL]. Chinese Journal of Lung Diseases(Electronic Edition), 2021, 14(04): 539-542.

1
Yadav D, Yadav SK, Khar RK, et al. Turmeric (Curcuma longa L.): A promising spice for phytochemical and pharmacological activities[J]. Int J Green Pharmacy, 2013, 7(2): 9-85.
2
Singh S. From exotic spice to modern drug?[J]. cell, 2007, 130(5): 765-768.
3
Kunnumakkara AB, Bordoloi D, Padmavathi G, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases[J]. Br J Pharmacol, 2017, 174(11): 1325-1348.
4
Yu X, Yu S, Chen L, et al. Tetrahydroberberrubine attenuates lipopolysaccharide-induced acute lung injury by down-regulating MAPK, AKTand NF-κappa B signaling pathways[J]. Biomed Pharmacother, 2016, 82: 489-497.
5
Faller S, Strosing KM, Ryter SW, et al.The volatile anesthetic isoflurane prevents ventilator-induced lung injury via phosphoinositide 3-kinase/Akt signaling in mice[J]. Anesth Analg, 2012, 114(4): 747-756.
6
Cheifetz IM. Year in review 2015: Pediatric ARDS[J]. Respir Care,2016, 61(7): 980-985.
7
Ding Q, Liu GQ, Zeng YY, et al. Role of IL-17 in LPS-induced acute lung injury: An in vivo study[J]. Oncotarget, 2017, 8(55): 93704-11.
8
Wang X, Song S, Hu Z, et al. Activation of Epac alleviates inflammation and vascular leakage in LPS-induced acute murine lung injury[J]. Biomed Pharmacother, 2017, 96: 1127-36.
9
Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome[J]. Clin Invest, 2012, 122(8): 2731-2740.
10
Zhang Y, Liu Z, Wu J, et al. New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity[J]. Eur J Med Chem, 2018, 148: 291-305.
11
Chai YS, Chen YQ, Lin SH, et al. Curcumin regulates the differentiation of naïve CD4+ T cells and activates IL-10 immune modulation against acute lung injury in mice[J]. Biomed Pharmacother, 2020, 125: 109946.
12
Cheng K, Yang A, Hu X, et al. Curcumin attenuates pulmonary inflammation in lipopolysaccharide induced acute lung injury in neonatal rat model by activating peroxisome proliferator-activated receptor γ (PPARγ) pathway[J]. Med Sci Monit, 2018, 24: 1178-1184.
13
Tsoyi K, Jang HJ, Nizamutdinova IT, et al. Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice[J]. Br J Pharmacol, 2011, 162(7): 1498-508.
14
Bae HB, Zmijewski JW, Deshane JS, et al. AMP-activated protein kinase enhances the phagocytic ability of macrophages and neutrophils[J]. FASEB J, 2011, 25(12): 4358-368.
15
Zhao X, Zmijewski JW, Lorne E, et al. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 2008, 295(3): L497-504.
16
Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling[J]. Circ Res, 2007, 100(3): 328-341.
17
Wang S, Song P, Zou MH. AMP-activated protein kinase, stress responses and cardiovascular diseases[J]. Clin Sci (Lond), 2012, 122(12): 555-573.
18
Ji G, Zhang Y, Yang Q, et al. Genistein suppresses LPS-induced inflammatory response through inhibiting NF-κB following AMP kinase activation in RAW 264.7 macrophages[J]. PLoS One, 2012, 7(12): e53101.
19
Kim J, Jeong SW, Quan H, et al. Effect of curcumin (Curcuma longa extract) on LPS-induced acute lung injury is mediated by the activation of AMPK[J]. J Anesth, 2016, 30(1): 100-108.
20
Xu F, Diao R, Liu J, et al. Curcumin attenuates staphylococcus aureus-induced acute lung injury[J]. Clin Respir J, 2015, 9(1): 87-97.
21
Xu Y, Liu L. Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-κB signaling pathway[J]. Influenza Other Respir Viruses, 2017, 11(5): 457-463.
22
Sun J, Yang D, Li S, et al. Effects of curcumin or dexamethasone on lung ischaemia-reperfusion injury in rats[J]. Eur Respir J, 2009, 33(2): 398-404.
23
Sun J, Guo W, Ben Y, et al. Preventive effects of curcumin and dexamethasone on lung transplantation-associated lung injury in rats[J]. Crit Care Med, 2008, 36(4): 1205-1213.
24
Wang X, An X, Wang X, et al. Curcumin ameliorated ventilator-induced lung injury in rats[J]. Biomed Pharmacother, 2018, 98: 754-761.
25
EliasJA, LeeCG, ZhengT, et al. New insights into the pathogenesis of asthma[J]. J Clin Invest, 2003, 111(3): 291-297.
26
Compalati E, Braido F, Canonica GW. An update on allergen immunotherapy and asthma[J]. Curr Opin Pulm Med, 2014, 20(1): 109-117.
27
Zhu T, Zhang W, Wang DX, et al. Rosuvastatin attenuates mucus secretion in a murine model of chronic asthma by inhibiting the gamma-aminobutyric acid type a receptor[J]. Chin Med J, 2012, 125(8): 1457-1464.
28
Gavino AC, Nahmod K, Bharadwaj U, et al. STAT3 inhibition prevents lung inflammation, remodeling, and accumulation of Th2 and Th17 cells in a murine asthma model[J]. Allergy, 2016, 71(12): 1684-1692.
29
Kumari A, Singh DK, Dash D, et al. Intranasal curcumin protects against LPS-induced airway remodeling by modulating toll-like receptor-4 (TLR-4) and matrixmetalloproteinase-9 (MMP-9) expression via affecting MAP kinases in mouse model[J]. Inflammo Pharma Cology, 2019, 27(4): 731-748.
30
Yang X, Lv JN, Li H, et al. Curcumin reduces lung inflammation via wnt/β-catenin signaling in mouse model of asthma[J]. J Asthma, 2017, 54(4): 335-340.
31
Zhu T, Chen ZH, Chen GH, et al. Curcumin attenuates asthmatic airway inflammation and mucus hypersecretion involving a PPARγ-dependent NF-κB signaling pathway in vivo and in vitro[J]. Mediators Inflamm, 2019: 4927430.
32
Chong L, Zhang W, Nie Y, et al. Protective effect of curcumin on acute airway inflammation of allergic asthma in mice through Notch1-GATA3 signaling pathway[J]. Inflammation, 2014, 37(5): 1476-1485.
33
Brewer JM, Conacher M, Hunter CA. Aluminium hydroxide adjuvantinitiates strong antigen-specific Th2 responses in the absence of IL-4-orIL-13-mediated signaling[J]. J Immunol, 1999, 163(12): 6448-6454.
34
Ma CH, Ma ZQ, Fu Q, et al. Curcumin attenuates allergic airway inflammation by regulation of CD4+ CD25+ regulatory T cells (Tregs)/Th17 balance in ovalbumin-densitized Mice[J]. Fitoterapia, 2013, 87: 57-64.
35
ConroyDM, Williams TJ. Eotaxin and the attraction of eosinophils to the asthmatic lung[J]. Respir Res, 2001, 2(3): 150-156.
36
AcevesSS, Newbury RO, Dohil MA, et al. A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation[J]. Ann Allergy Asthma Immunol, 2009, 103(5): 401-406.
37
Bodas M, Patel N, Silverberg D, et al. Master autophagy regulator Transcription factor-EB (TFEB) regulatescigarette smoke induced autophagy-impairment and COPD-emphysema pathogenesis[J]. Antioxid Redox Signal, 2017, 27(3): 150-167.
38
Wu S, Xiao D. Effect of curcumin on nasal symptoms and airflow in patients withperennial allergic rhinitis[J]. Ann Allergy Asthma Immunol, 2016, 117(6): 697-702.
39
Dhillon B, Aggarwal BB, Newman RA, et al. Phase Ⅱ trial of curcumin in patients with advanced pancreatic cancer[J]. Clin Cancer Res, 2008, 14(14): 4491-4499.
40
Chuang EY, Lin KJ, Huang TY, et al. An intestinal "Transformers" -like nanocarrier system for enhancing the oral bioavailability of poorly water-soluble drugs[J]. ACS Nano, 2018, 12(7): 6389-6397.
[1] 王丹, 李文思, 成苏杭, 吉泽, 朱祥, 郝春艳. Treg/Th17 及DC 细胞水平在COPD不同疾病进展期的表达及其与预后的关系[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 685-689.
[2] 沈琪乐, 赵勤华, 宫素岗, 刘锦铭, 王岚, 邱宏玲. COPD 稳定期患者血清CC16 蛋白表达与肺功能、肺气肿表型的关系分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 690-695.
[3] 张敏龙, 杨翠平, 王博, 崔云杰, 金发光. MiR-200b-3p 通过抑制HIF-1α 表达减轻海水吸入诱导的肺水肿作用及机制[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 696-700.
[4] 郭璟琪, 魏明言, 刘芳, 李冬凌, 关金平, 李立华. 乙酰半胱氨酸治疗慢性阻塞性肺疾病急性加重期的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 768-772.
[5] 王石林, 叶继章, 丘向艳, 陈桂青, 邹晓敏. 慢性阻塞性肺疾病真菌感染风险早期预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 773-776.
[6] 赵小欢, 尚志英, 段文超, 张晓燕, 孙东强. 无创通气治疗COPD 并发呼吸衰竭不同预后患者外周血MicroRNA及炎性因子水平分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 777-780.
[7] 曹健, 冯高华, 周卫军, 陈诚, 沈王丰, 吴英姿. 补脾益肺膏联合肺康复训练治疗慢性阻塞性肺疾病的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 781-784.
[8] 詹济玮, 蔡柳春, 温琼娜, 郭石生, 温春妹, 温鹤明. 布地格福联合噻托溴铵治疗AECOPD 的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 823-826.
[9] 刘璐璐, 何羽. 慢性阻塞性肺病患者睡眠障碍的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 836-839.
[10] 陈嘉艺, 陈佳, 张曦, 张琦. 伴有“反晕征”的IgG4 相关性肺疾病一例并文献复习[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 844-846.
[11] 马锦芳, 何正光, 郑劲平. 盐酸氨溴索雾化吸入治疗慢性阻塞性肺疾病黏痰症患者的疗效和安全性分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 568-574.
[12] 程炜炜, 张青, 张诚实, 冯契靓, 陈荣荣, 赵云峰. 全身免疫炎症指数与慢性阻塞性肺疾病急性加重期病情严重程度相关性分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 580-584.
[13] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
[14] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[15] 闫维, 张二明, 张克, 安欣华, 向平超. 北京市石景山区40岁及以上居民早期慢性阻塞性肺疾病异质性及影响因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 533-540.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?